188 related articles for article (PubMed ID: 37467813)
1. Oral liposomes encapsulating ginsenoside compound K for rheumatoid arthritis therapy.
Li Z; Han S; Cui G; Xue B; Li J; Man Y; Zhang H; Teng L
Int J Pharm; 2023 Aug; 643():123247. PubMed ID: 37467813
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside compound K- a potential drug for rheumatoid arthritis.
Tang M; Xie X; Yang Y; Li F
Pharmacol Res; 2021 Apr; 166():105498. PubMed ID: 33609698
[TBL] [Abstract][Full Text] [Related]
3. Folate-conjugated hydrophobicity modified glycol chitosan nanoparticles for targeted delivery of methotrexate in rheumatoid arthritis.
Wu Z; Xu K; Min J; Chen M; Shen L; Xu J; Jiang Q; Han G; Pan L; Li H
J Appl Biomater Funct Mater; 2020; 18():2280800020962629. PubMed ID: 33155513
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of various ginsenosides on rheumatoid arthritis.
Zhang M; Ren H; Li K; Xie S; Zhang R; Zhang L; Xia J; Chen X; Li X; Wang J
BMC Complement Med Ther; 2021 May; 21(1):149. PubMed ID: 34034706
[TBL] [Abstract][Full Text] [Related]
5. Folate-modified triptolide liposomes target activated macrophages for safe rheumatoid arthritis therapy.
Guo RB; Zhang XY; Yan DK; Yu YJ; Wang YJ; Geng HX; Wu YN; Liu Y; Kong L; Li XT
Biomater Sci; 2022 Jan; 10(2):499-513. PubMed ID: 34904598
[TBL] [Abstract][Full Text] [Related]
6. TPGS-modified liposomes for the delivery of ginsenoside compound K against non-small cell lung cancer: formulation design and its evaluation in vitro and in vivo.
Yang L; Xin J; Zhang Z; Yan H; Wang J; Sun E; Hou J; Jia X; Lv H
J Pharm Pharmacol; 2016 Sep; 68(9):1109-18. PubMed ID: 27368109
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate-loaded folic acid of solid-phase synthesis conjugated gold nanoparticles targeted treatment for rheumatoid arthritis.
Li X; Wang H; Zou X; Su H; Li C
Eur J Pharm Sci; 2022 Mar; 170():106101. PubMed ID: 34936935
[TBL] [Abstract][Full Text] [Related]
8. Targeted therapy of rheumatoid arthritis via macrophage repolarization.
Zhou X; Huang D; Wang R; Wu M; Zhu L; Peng W; Tu H; Deng X; Zhu H; Zhang Z; Wang X; Cao X
Drug Deliv; 2021 Dec; 28(1):2447-2459. PubMed ID: 34766540
[TBL] [Abstract][Full Text] [Related]
9. Folate receptor-targeted mixed polysialic acid micelles for combating rheumatoid arthritis: in vitro and in vivo evaluation.
Zhang N; Xu C; Li N; Zhang S; Fu L; Chu X; Hua H; Zeng X; Zhao Y
Drug Deliv; 2018 Nov; 25(1):1182-1191. PubMed ID: 29790372
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound-targeted microbubble destruction augmented synergistic therapy of rheumatoid arthritis via targeted liposomes.
Wang L; Zhu B; Huang J; Xiang X; Tang Y; Ma L; Yan F; Cheng C; Qiu L
J Mater Chem B; 2020 Jun; 8(24):5245-5256. PubMed ID: 32432638
[TBL] [Abstract][Full Text] [Related]
11. Folate Conjugated Double Liposomes Bearing Prednisolone and Methotrexate for Targeting Rheumatoid Arthritis.
Verma A; Jain A; Tiwari A; Saraf S; Panda PK; Agrawal GP; Jain SK
Pharm Res; 2019 Jun; 36(8):123. PubMed ID: 31218557
[TBL] [Abstract][Full Text] [Related]
12. Folate-targeted nanoparticles for rheumatoid arthritis therapy.
Nogueira E; Gomes AC; Preto A; Cavaco-Paulo A
Nanomedicine; 2016 May; 12(4):1113-1126. PubMed ID: 26733257
[TBL] [Abstract][Full Text] [Related]
13. Co-Delivery of Daunorubicin and Homoharringtonine in Folic Acid Modified-Liposomes for Enhancing Therapeutic Effect on Acute Myeloid Leukemia.
Liu Q; Luo L; Gao X; Zhang D; Feng X; Yang P; Li H; Mao S
J Pharm Sci; 2023 Jan; 112(1):123-131. PubMed ID: 35469834
[TBL] [Abstract][Full Text] [Related]
14. Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR Cells.
Sriraman SK; Pan J; Sarisozen C; Luther E; Torchilin V
Mol Pharm; 2016 Feb; 13(2):428-37. PubMed ID: 26702994
[TBL] [Abstract][Full Text] [Related]
15. Long-Circulating Lipid Nanospheres Loaded with Flurbiprofen Axetil for Targeted Rheumatoid Arthritis Treatment.
Chen Z; Liu Z; Wang S; Cheng C; Sun X; Liu Z; Wei J; Jiang J; Lan H; Zhou M; Jing P; Lin Y; Zhou X; Zhong Z
Int J Nanomedicine; 2023; 18():5159-5181. PubMed ID: 37705869
[TBL] [Abstract][Full Text] [Related]
16. Folate and TAT peptide co-modified liposomes exhibit receptor-dependent highly efficient intracellular transport of payload in vitro and in vivo.
Zhu Y; Cheng L; Cheng L; Huang F; Hu Q; Li L; Tian C; Wei L; Chen D
Pharm Res; 2014 Dec; 31(12):3289-303. PubMed ID: 24858397
[TBL] [Abstract][Full Text] [Related]
17. ROS-mediated liposomal dexamethasone: a new FA-targeted nanoformulation to combat rheumatoid arthritis
Song Y; Ismail M; Shan Q; Zhao J; Zhu Y; Zhang L; Du Y; Ling L
Nanoscale; 2021 Dec; 13(47):20170-20185. PubMed ID: 34846489
[TBL] [Abstract][Full Text] [Related]
18. Exosome-based biomimetic nanoparticles targeted to inflamed joints for enhanced treatment of rheumatoid arthritis.
Yan F; Zhong Z; Wang Y; Feng Y; Mei Z; Li H; Chen X; Cai L; Li C
J Nanobiotechnology; 2020 Aug; 18(1):115. PubMed ID: 32819405
[TBL] [Abstract][Full Text] [Related]
19. Flexible nano-liposomes-based transdermal hydrogel for targeted delivery of dexamethasone for rheumatoid arthritis therapy.
Zhao YP; Han JF; Zhang FY; Liao TT; Na R; Yuan XF; He GB; Ye W
Drug Deliv; 2022 Dec; 29(1):2269-2282. PubMed ID: 35815790
[TBL] [Abstract][Full Text] [Related]
20. Role of Liposome Size, Surface Charge, and PEGylation on Rheumatoid Arthritis Targeting Therapy.
Ren H; He Y; Liang J; Cheng Z; Zhang M; Zhu Y; Hong C; Qin J; Xu X; Wang J
ACS Appl Mater Interfaces; 2019 Jun; 11(22):20304-20315. PubMed ID: 31056910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
